In a 5-4 vote, the U.S. Supreme Court ruled on Monday that drug makers cannot be sued under state law for adverse reactions to generic drugs. In writing the majority opinion, Justice Samuel Alito said that state laws cannot run against federal laws when drugs have been approved by the FDA. “Today’s court decision provides a disincentive for generic makers of drugs to monitor safety of their products and to make sure that they have a surveillance system in place to detect adverse events that pose a threat to patients,” said Michael Carome, director of Public Citizen’s Health Research Group.
Further interest:
Supreme Court rules Drug Companies exempt from Lawsuits (Whiteout Press)
